Works matching IS 03618609 AND DT 2024 AND VI 99 AND IP 2
Results: 31
Unraveling the mystery of the spleen.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. 150, doi. 10.1002/ajh.27200
- By:
- Publication type:
- Article
Comparison of fludarabine‐based conditioning regimens in adult cord blood transplantation for myeloid malignancy: A retrospective, registry‐based study.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. 236, doi. 10.1002/ajh.27172
- By:
- Publication type:
- Article
Vacuoles in circulating immature myeloid cells in VEXAS syndrome and comparison with UBA1‐wild type patients.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. E60, doi. 10.1002/ajh.27192
- By:
- Publication type:
- Article
Toward an improved understanding of hypomethylating agent and venetoclax therapies.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. 152, doi. 10.1002/ajh.27178
- By:
- Publication type:
- Article
Immunoglobulin light chain amyloidosis: 2024 update on diagnosis, prognosis, and treatment.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. 309, doi. 10.1002/ajh.27177
- By:
- Publication type:
- Article
Long‐term treatment with fostamatinib in Japanese patients with primary immune thrombocytopenia: An open‐label extension study following a phase 3 placebo‐controlled, double‐blind, parallel‐group study.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. E55, doi. 10.1002/ajh.27176
- By:
- Publication type:
- Article
Safety and efficacy of a new high‐dose regimen of panobinostat, gemcitabine, busulfan, and melphalan for 1st or 2nd salvage ASCT for refractory/relapsed or high‐risk myeloma: Matched‐pair comparisons with concurrent control cohorts.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. 245, doi. 10.1002/ajh.27168
- By:
- Publication type:
- Article
Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. E63, doi. 10.1002/ajh.27180
- By:
- Publication type:
- Article
Phase Ib study of sabatolimab (MBG453), a novel immunotherapy targeting TIM‐3 antibody, in combination with decitabine or azacitidine in high‐ or very high‐risk myelodysplastic syndromes.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. E32, doi. 10.1002/ajh.27161
- By:
- Publication type:
- Article
Hematopoietic stem cell transplantation from haploidentical offspring donors using post‐transplant cyclophosphamide versus human leukocyte antigen‐matched siblings in older patients with myelodysplastic syndrome.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. E42, doi. 10.1002/ajh.27160
- By:
- Publication type:
- Article
Risk factors and clinical impact of thrombosis during induction chemotherapy for pediatric acute lymphoblastic leukemia: A report from CYP‐C.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. 274, doi. 10.1002/ajh.27171
- By:
- Publication type:
- Article
Association of individual comorbidities with outcomes in allogeneic hematopoietic cell transplantation from unrelated adult donors versus unrelated cord blood: A study on behalf of the Donor/Source and Transplant Complications Working Groups of the Japanese Society for Transplantation and Cellular Therapy
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. 263, doi. 10.1002/ajh.27174
- By:
- Publication type:
- Article
Dosage of high‐dose methotrexate as CNS prophylaxis in DLBCL: A detailed analysis of toxicity and impact on CNS relapse.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. E46, doi. 10.1002/ajh.27167
- By:
- Publication type:
- Article
Momelotinib expands the therapeutic armamentarium for myelofibrosis: Impact on hierarchy of treatment choices.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. 300, doi. 10.1002/ajh.27163
- By:
- Publication type:
- Article
Mutation landscape of normal karyotype myelodysplastic syndromes and their prognostic impact.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. E51, doi. 10.1002/ajh.27170
- By:
- Publication type:
- Article
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. 254, doi. 10.1002/ajh.27169
- By:
- Publication type:
- Article
Elevated MCHC reveals a Southeast Asian Ovalocytosis.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. 331, doi. 10.1002/ajh.27157
- By:
- Publication type:
- Article
VEXAS syndrome: Clinical, hematologic features and a practical approach to diagnosis and management.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. 284, doi. 10.1002/ajh.27156
- By:
- Publication type:
- Article
Comparative pharmacovigilance assessment of adverse events associated with the use of hydroxyurea, L‐glutamine, voxelotor, and crizanlizumab in sickle cell disease.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. E37, doi. 10.1002/ajh.27153
- By:
- Publication type:
- Article
Retention of uninfected red blood cells causing congestive splenomegaly is the major mechanism of anemia in malaria.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. 223, doi. 10.1002/ajh.27152
- By:
- Publication type:
- Article
R‐miniCHOP versus R‐CHOP in elderly patients with diffuse large B‐cell lymphoma: A propensity matched population‐based study.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. 216, doi. 10.1002/ajh.27151
- By:
- Publication type:
- Article
Outcomes of CMML patients undergoing allo‐HCT are significantly worse compared to MDS—a study of the CMWP of the EBMT.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. 203, doi. 10.1002/ajh.27150
- By:
- Publication type:
- Article
Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. 193, doi. 10.1002/ajh.27138
- By:
- Publication type:
- Article
Cerebral hemodynamics and oxygenation in adult patients with sickle cell disease after stem cell transplantation.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. 163, doi. 10.1002/ajh.27135
- By:
- Publication type:
- Article
Bone marrow granulomatous reaction to silicone from breast implants.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. 325, doi. 10.1002/ajh.27116
- By:
- Publication type:
- Article
Long‐term risk of venous thromboembolism among patients with gastrointestinal non‐neoplastic and neoplastic diseases: A prospective cohort study of 484 211 individuals.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. 172, doi. 10.1002/ajh.27106
- By:
- Publication type:
- Article
Luspatercept stimulates erythropoiesis, increases iron utilization, and redistributes body iron in transfusion‐dependent thalassemia.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. 182, doi. 10.1002/ajh.27102
- By:
- Publication type:
- Article
Avatrombopag for adults with early versus chronic immune thrombocytopenia.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. 155, doi. 10.1002/ajh.27080
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. 147, doi. 10.1002/ajh.26972
- Publication type:
- Article
Utility of p53 immunohistochemistry as a surrogate for sequencing in myeloid neoplasms: A tale of caution.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. 329, doi. 10.1002/ajh.26970
- By:
- Publication type:
- Article
Two p53s in a Pod: Co‐occurring plasma cell myeloma and therapy‐related myeloid neoplasm following lenalidomide therapy.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. 327, doi. 10.1002/ajh.26930
- By:
- Publication type:
- Article